Article Text

PDF
Qualitative study—other
Individualised assessment is required to establish the most appropriate anticoagulation option for patients
  1. Michelle Kennedy
  1. Faculty of Health Sciences, University of Hull, Hull, UK
  1. Correspondence to Michelle Kennedy, University of Hull, Aire Building, Hull HU6 7RX, UK; M.L.Kennedy{at}hull.ac.uk

Statistics from Altmetric.com

Commentary on: Ferguson C, Inglis SC, Newton PJ, et al. Barriers and enablers to adherence to anticoagulation in heart failure with atrial fibrillation: patient and provider perspectives. J Clin Nurs 2017: [Epub ahead of print: 8 Feb 2017].

Implications for practice and research

  • Healthcare professionals need to be aware that age and falls risk are not in themselves barriers to anticoagulation therapy. Anticoagulation therapy should not be withheld based on these factors alone.

  • Future research should focus on establishing enablers to anticoagulation therapy with the aim of improving compliance.

Context

Atrial fibrillation (AF) currently affects approximately 2% of the population of the Western countries.1 The prevalence of AF rises with concomitant cardiovascular disease, and up to one-third of people with heart failure will also suffer from AF.2 These figures are set to rise further with the continuing ageing population. It is estimated that the number of new AF cases in Europe will rise …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.